Michael Gelband’s Axonics, Inc. Common Stock AXNX Stock Holding History

Michael Gelband’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,298	Closed	-$578K	–	2158
2023 Q3	$578K	Sell	10,298 -5,903	-36%	-$332K	0.01%	1188
2023 Q2	$818K	Sell	16,201 -28,021	-63%	-$1.49M	0.01%	1179
2023 Q1	$2.41M	Buy	44,222 +6,784	+18%	+$396K	0.02%	802
2022 Q4	$2.34M	Buy	37,438 +27,836	+290%	+$1.85M	0.03%	580
2022 Q3	$676K	Sell	9,602 -7,696	-44%	-$531K	0.01%	1263
2022 Q2	$980K	Buy	+17,298	New	+$948K	0.01%	1090
2021 Q1	–	Sell	-290	Closed	-$14K	–	2700
2020 Q4	$14K	Buy	+290	New	+$13.6K	﹤0.01%	1893
2019 Q3	–	Sell	-52,108	Closed	-$2.13M	–	1700
2019 Q2	$2.13M	Buy	+52,108	New	+$1.47M	0.08%	147

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Michael Gelband's AXNX Position: Q4 2023 in Review

Michael Gelband sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 10,298 shares — an estimated $578K sold.

Michael Gelband first reported a position in AXNX in Q2 2019 and held it in 8 quarters. The position peaked at $2.41M in Q1 2023. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Michael Gelband reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Michael Gelband sold 10,298 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $578K.
Michael Gelband first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Michael Gelband's Axonics, Inc. Common Stock position peaked at $2.41M in Q1 2023.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.